Articles with "intravesical bcg" as a keyword



Photo from wikipedia

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients

Sign Up to like & get
recommendations!
Published in 2017 at "Scientific Reports"

DOI: 10.1038/s41598-017-01532-7

Abstract: To evaluate the influence of patient-associated parameters and comorbities, with a special focus on renal function after intravesical adjuvant bacillus Calmette-Gue´rin (BCG) immunotherapy in patients with non–muscle-invasive bladder cancer (NMIBC). We retrospectively reviewed the medical… read more here.

Keywords: recurrence; muscle invasive; non muscle; renal function ... See more keywords

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections

Sign Up to like & get
recommendations!
Published in 2022 at "Journal for Immunotherapy of Cancer"

DOI: 10.1136/jitc-2022-005518

Abstract: Background BCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces trained immunity. Methods The… read more here.

Keywords: intravesical bcg; trained immunity; induces trained; bcg ... See more keywords
Photo from wikipedia

Pleural effusion as a late complication of intravesical BCG treatment

Sign Up to like & get
recommendations!
Published in 2017 at "Thorax"

DOI: 10.1136/thoraxjnl-2017-210634

Abstract: Amy Gray (Junior Doctor) : An 88-year-old man with a background of transitional cell bladder cancer diagnosed in 2012 was referred to the ambulatory care clinic with a 1-month history of increasing breathlessness. He had constitutional symptoms… read more here.

Keywords: left sided; pleural effusion; sided pleural; effusion ... See more keywords
Photo from wikipedia

Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.

Sign Up to like & get
recommendations!
Published in 2023 at "Urologia internationalis"

DOI: 10.1159/000528740

Abstract: INTRODUCTION In this study, we aimed to explore using the predictive role of systemic immune inflammation index (SII) for responses of intravesical Bacillus Calmette-Guérin (BCG) therapy in patients with intermediate- and high-risk non-muscle-invasive bladder cancer… read more here.

Keywords: intermediate high; intravesical bcg; high risk; sii ... See more keywords
Photo from wikipedia

Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Translational Medicine"

DOI: 10.1186/s12967-019-1778-6

Abstract: BackgroundWe set out to determine if the administration of subcutaneous (SQ) ALT-803 was non-inferior to standard intravesical BCG treatment in a carcinogen induced mouse (C57BL/6J) bladder cancer model.MethodsUsing this well-established carcinogen induced mouse model, we… read more here.

Keywords: 803 alone; bladder; model; alt 803 ... See more keywords
Photo from wikipedia

Investigation of the frequency of COVID-19 in patients treated with intravesical BCG.

Sign Up to like & get
recommendations!
Published in 2020 at "Revista da Associacao Medica Brasileira"

DOI: 10.1590/1806-9282.66.s2.91

Abstract: INTRODUCTION In this retrospective study, we aimed to investigate the frequency of COVID-19 in patients with and without BCG application due to bladder tumors. METHODS The presence of COVID-19 was investigated in 167 patients with… read more here.

Keywords: frequency covid; covid patients; intravesical bcg; covid ... See more keywords

Bacillus Calmette-Guérin Spondylodiscitis after Intravesical BCG Therapy: A Case Report

Sign Up to like & get
recommendations!
Published in 2022 at "Spine Surgery and Related Research"

DOI: 10.22603/ssrr.2022-0009

Abstract: Figure 1-a. Sagittal plane computed tomography (CT) scan at first visit. CT shows osteolytic lesion on T9–T10. The arrow marks T9. Fig. 1-b Sagittal magnetic resonance imaging (MRI) images at first visit. Left: T1-weighted image.… read more here.

Keywords: bcg therapy; calmette rin; intravesical bcg; rin spondylodiscitis ... See more keywords